What was Naturewise Biotech & Medicals Corporation’s price range in the past 12 months?
Naturewise Biotech & Medicals Corporation lowest stock price was TWD 14.70 and its highest was TWD 24.60 in the past 12 months.
What is Naturewise Biotech & Medicals Corporation’s market cap?
Naturewise Biotech & Medicals Corporation’s market cap is TWD 734.72M.
When is Naturewise Biotech & Medicals Corporation’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Naturewise Biotech & Medicals Corporation overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Naturewise Biotech & Medicals Corporation pay dividends?
Naturewise Biotech & Medicals Corporation pays a ― dividend of TWD 0.2 which represents an annual dividend yield of ―. See more information on Naturewise Biotech & Medicals Corporation dividends here
What is Naturewise Biotech & Medicals Corporation’s EPS estimate?
Naturewise Biotech & Medicals Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Naturewise Biotech & Medicals Corporation have?
Naturewise Biotech & Medicals Corporation has 49,643,500 shares outstanding.
Which hedge fund is a major shareholder of Naturewise Biotech & Medicals Corporation?
Currently, no hedge funds are holding shares in TW:4732
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Naturewise Biotech & Medicals Corporation
NatureWise Biotech & Medicals Corporation is a Taiwanese entity primarily engaged in the creation of pharmaceutical solutions. Its product lineup features LipoCol Forte, a capsule designed to address elevated cholesterol and triglyceride levels; PPL Taiwan green propolis; and NBM-BMX, an oral softgel formulation specifically developed for oncology treatment. The company was established in 2000 and maintains its headquarters in Taipei, Taiwan.